Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Talevich

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Pathology|January 29, 2019
Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinomaNancy M Joseph, Christos G Tsokos, Sarah E Umetsu, et al.
The New England Journal of Medicine|November 13, 2015
The Genetic Evolution of Melanoma from Precursor LesionsA Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2017
Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activationBenjamin Goode, Nancy M Joseph, Meredith Stevers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomasGregor Krings, Nancy M Joseph, Gregory R Bean, et al.
Cell Reports|October 17, 2019
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug ResponsesThomas Botton, Eric Talevich, Vivek Kumar Mishra, et al.
Nature Communications|May 28, 2015
Activating MET kinase rearrangements in melanoma and Spitz tumoursIwei Yeh, Thomas Botton, Eric Talevich, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 4, 2016
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneitySu-Yang Liu, Nancy M Joseph, Ajay Ravindranathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical QualificationGeorge Seed, Wei Yuan, Joaquin Mateo, et al.
Genome Medicine|June 2, 2021
Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluidsWei Gu, Eric Talevich, Elaine Hsu, et al.
Nature Genetics|September 8, 2015
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathwayA Hunter Shain, Maria Garrido, Thomas Botton, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Pathology|January 29, 2019
Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinomaNancy M Joseph, Christos G Tsokos, Sarah E Umetsu, et al.
The New England Journal of Medicine|November 13, 2015
The Genetic Evolution of Melanoma from Precursor LesionsA Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2017
Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activationBenjamin Goode, Nancy M Joseph, Meredith Stevers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomasGregor Krings, Nancy M Joseph, Gregory R Bean, et al.
Cell Reports|October 17, 2019
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug ResponsesThomas Botton, Eric Talevich, Vivek Kumar Mishra, et al.
Nature Communications|May 28, 2015
Activating MET kinase rearrangements in melanoma and Spitz tumoursIwei Yeh, Thomas Botton, Eric Talevich, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 4, 2016
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneitySu-Yang Liu, Nancy M Joseph, Ajay Ravindranathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical QualificationGeorge Seed, Wei Yuan, Joaquin Mateo, et al.
Genome Medicine|June 2, 2021
Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluidsWei Gu, Eric Talevich, Elaine Hsu, et al.
Nature Genetics|September 8, 2015
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathwayA Hunter Shain, Maria Garrido, Thomas Botton, et al.
Pageof 3